The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000152.5(GAA):c.806_830del (p.Leu269fs)

CA915952247

656144 (ClinVar)

Gene: GAA
Condition: glycogen storage disease II
Inheritance Mode: Autosomal recessive inheritance
UUID: 0ad423df-1060-458b-8ee9-3a8e9b43de5e
Approved on: 2023-03-10
Published on: 2023-03-10

HGVS expressions

NM_000152.5:c.806_830del
NM_000152.5(GAA):c.806_830del (p.Leu269fs)
NC_000017.11:g.80107670_80107694del
CM000679.2:g.80107670_80107694del
NC_000017.10:g.78081469_78081493del
CM000679.1:g.78081469_78081493del
NC_000017.9:g.75696064_75696088del
NG_009822.1:g.11115_11139del
ENST00000302262.8:c.806_830del
ENST00000302262.7:c.806_830del
ENST00000390015.7:c.806_830del
ENST00000570803.5:c.806_830del
NM_000152.3:c.806_830del
NM_001079803.1:c.806_830del
NM_001079804.1:c.806_830del
NM_000152.4:c.806_830del
NM_001079803.2:c.806_830del
NM_001079804.2:c.806_830del
NM_001079803.3:c.806_830del
NM_001079804.3:c.806_830del

Likely Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"
Met criteria codes 2
PM2_Supporting PVS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Lysosomal Diseases VCEP
The NM_000152.5:c.806_830del (p.Leu269ProfsTer37) variant in GAA is a frameshift variant predicted to cause a premature stop codon, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is not in gnomAD v2.1.1. (PM2_Supporting). To our knowledge, this variant has not been reported in a patient with Pompe disease in the literature, and results of functional studies are not available. There is a ClinVar entry for this variant (Variation ID: 656144). The classification of this variant has been upgraded from Variant of Uncertain Significance to Likely Pathogenic based on the recommendations of the ClinGen Sequence Variant Interpretation Working Group, that a variant meeting PVS1 and PM2_Supporting is classified as Likely Pathogenic (https://clinicalgenome.org/site/assets/files/5182/pm2_-_svi_recommendation_-_approved_sept2020.pdf ). In summary, this variant meets the criteria to be classified as Likely Pathogenic for Pompe disease. GAA-specific ACMG/AMP criteria met, based on the specifications of the ClinGen Lysosomal Diseases VCEP (Specifications Version 2.0): PVS1, PM2_Supporting. (Classification approved by the ClinGen Lysosomal Diseases VCEP, March 10, 2023).
Met criteria codes
PM2_Supporting
This variant is not in gnomAD v2.1.1. (PM2_Supporting)
PVS1
The NM_000152.5:c.806_830del (p.Leu269ProfsTer37) variant in GAA is a frameshift variant predicted to cause a premature stop codon, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.